Ici une étude qui trouve une mortalité nettement diminuée lors de l’emploi d’anticoagulants chez les patients #COVID-19 sous intubation avec ventilation assistée.
Association of Treatment Dose Anticoagulation with In-Hospital Survival Among Hospitalized Patients with COVID-19 | JACC : Journal of the American College of Cardiology
▻http://www.onlinejacc.org/content/early/2020/05/05/j.jacc.2020.05.001
In patients who required mechanical ventilation (N=395), in-hospital mortality was 29.1% with a median survival of 21 days for those treated with AC as compared to 62.7% with a median survival of 9 days in patients who did not receive AC (Figure 1B). In a multivariate proportional hazards model, longer duration of AC treatment was associated with a reduced risk of mortality (adjusted HR of 0.86 per day, 95% confidence interval 0.82-0.89, p<0.001).